Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

Variation in accessibility of the population to an Emergency Medical Communication Centre: a multicentre observational study.

Penverne Y, Leclere B, Lecarpentier E, Marx JS, Gicquel B, Goix L, Reuter PG.

Scand J Trauma Resusc Emerg Med. 2019 Oct 28;27(1):94. doi: 10.1186/s13049-019-0667-6.

2.

Publisher Correction: M. tuberculosis infection and antigen specific cytokine response in healthcare workers frequently exposed to tuberculosis.

Essone PN, Leboueny M, Maloupazoa Siawaya AC, Alame-Emane AK, Aboumegone Biyogo OC, Dapnet Tadatsin PH, Mveang Nzoghe A, Essamazokou DU, Mvoundza Ndjindji O, Padzys GS, Agnandji ST, Takiff H, Gicquel B, Djoba Siawaya JF.

Sci Rep. 2019 Oct 23;9(1):15415. doi: 10.1038/s41598-019-50847-0.

3.

M. tuberculosis infection and antigen specific cytokine response in healthcare workers frequently exposed to tuberculosis.

Essone PN, Leboueny M, Maloupazoa Siawaya AC, Alame-Emane AK, Aboumegone Biyogo OC, Dapnet Tadatsin PH, Mveang Nzoghe A, Essamazokou DU, Mvoundza Ndjindji O, Padzys GS, Agnandji ST, Takiff H, Gicquel B, Djoba Siawaya JF.

Sci Rep. 2019 Jun 3;9(1):8201. doi: 10.1038/s41598-019-44294-0. Erratum in: Sci Rep. 2019 Oct 23;9(1):15415.

4.

Genome-Wide Transcriptional Responses of Mycobacterium to Antibiotics.

Briffotaux J, Liu S, Gicquel B.

Front Microbiol. 2019 Feb 20;10:249. doi: 10.3389/fmicb.2019.00249. eCollection 2019. Review.

5.

Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection.

Coya JM, De Matteis L, Giraud-Gatineau A, Biton A, Serrano-Sevilla I, Danckaert A, Dillies MA, Gicquel B, De la Fuente JM, Tailleux L.

J Nanobiotechnology. 2019 Jan 25;17(1):15. doi: 10.1186/s12951-018-0439-x.

6.

High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds.

Zampieri M, Szappanos B, Buchieri MV, Trauner A, Piazza I, Picotti P, Gagneux S, Borrell S, Gicquel B, Lelievre J, Papp B, Sauer U.

Sci Transl Med. 2018 Feb 21;10(429). pii: eaal3973. doi: 10.1126/scitranslmed.aal3973.

7.

B Cells Producing Type I IFN Modulate Macrophage Polarization in Tuberculosis.

Bénard A, Sakwa I, Schierloh P, Colom A, Mercier I, Tailleux L, Jouneau L, Boudinot P, Al-Saati T, Lang R, Rehwinkel J, Loxton AG, Kaufmann SHE, Anton-Leberre V, O'Garra A, Sasiain MDC, Gicquel B, Fillatreau S, Neyrolles O, Hudrisier D.

Am J Respir Crit Care Med. 2018 Mar 15;197(6):801-813. doi: 10.1164/rccm.201707-1475OC.

8.

MmpS5/MmpL5 as an efflux pump in Mycobacterium species.

Briffotaux J, Huang W, Wang X, Gicquel B.

Tuberculosis (Edinb). 2017 Dec;107:13-19. doi: 10.1016/j.tube.2017.08.001. Epub 2017 Aug 4. Review.

PMID:
29050760
9.

Ionophore A23187 shows anti-tuberculosis activity and synergy with tebipenem.

Huang W, Briffotaux J, Wang X, Liu L, Hao P, Cimino M, Buchieri MV, Namouchi A, Ainsa JA, Gicquel B.

Tuberculosis (Edinb). 2017 Dec;107:111-118. doi: 10.1016/j.tube.2017.09.001. Epub 2017 Sep 6.

PMID:
29050757
10.

Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids.

Blanc L, Gilleron M, Prandi J, Song OR, Jang MS, Gicquel B, Drocourt D, Neyrolles O, Brodin P, Tiraby G, Vercellone A, Nigou J.

Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11205-11210. doi: 10.1073/pnas.1707840114. Epub 2017 Oct 2.

11.

Nitazoxanide Analogs Require Nitroreduction for Antimicrobial Activity in Mycobacterium smegmatis.

Buchieri MV, Cimino M, Rebollo-Ramirez S, Beauvineau C, Cascioferro A, Favre-Rochex S, Helynck O, Naud-Martin D, Larrouy-Maumus G, Munier-Lehmann H, Gicquel B.

J Med Chem. 2017 Sep 14;60(17):7425-7433. doi: 10.1021/acs.jmedchem.7b00726. Epub 2017 Aug 28.

PMID:
28846409
12.

Phenotypic and genomic comparison of Mycobacterium aurum and surrogate model species to Mycobacterium tuberculosis: implications for drug discovery.

Namouchi A, Cimino M, Favre-Rochex S, Charles P, Gicquel B.

BMC Genomics. 2017 Jul 13;18(1):530. doi: 10.1186/s12864-017-3924-y.

13.

Recombinant BCG Expressing LTAK63 Adjuvant induces Superior Protection against Mycobacterium tuberculosis.

Nascimento IP, Rodriguez D, Santos CC, Amaral EP, Rofatto HK, Junqueira-Kipnis AP, Gonçalves EDC, D'Império-Lima MR, Hirata MH, Silva CL, Winter N, Gicquel B, Mills KHG, Pizza M, Rappuoli R, Leite LCC.

Sci Rep. 2017 May 18;7(1):2109. doi: 10.1038/s41598-017-02003-9.

14.

Use of GeneXpert Remnants for Drug Resistance Profiling and Molecular Epidemiology of Tuberculosis in Libreville, Gabon.

Alame-Emane AK, Pierre-Audigier C, Aboumegone-Biyogo OC, Nzoghe-Mveang A, Cadet-Daniel V, Sola C, Djoba-Siawaya JF, Gicquel B, Takiff HE.

J Clin Microbiol. 2017 Jul;55(7):2105-2115. doi: 10.1128/JCM.02257-16. Epub 2017 Apr 26.

15.

Experimental infection of New Zealand Merino sheep with a suspension of Mycobacterium avium subspecies paratuberculosis (Map) strain Telford: Kinetics of the immune response, histopathology and Map culture.

Dukkipati VSR, Ridler AL, Thompson KG, Buddle BM, Hedgespeth BA, Price-Carter M, Begg DJ, Whittington RJ, Gicquel B, Murray A.

Vet Microbiol. 2016 Nov 15;195:136-143. doi: 10.1016/j.vetmic.2016.09.018. Epub 2016 Sep 23.

16.

Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination.

Polena H, Boudou F, Tilleul S, Dubois-Colas N, Lecointe C, Rakotosamimanana N, Pelizzola M, Andriamandimby SF, Raharimanga V, Charles P, Herrmann JL, Ricciardi-Castagnoli P, Rasolofo V, Gicquel B, Tailleux L.

Sci Rep. 2016 Sep 12;6:33162. doi: 10.1038/srep33162.

17.

Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in China.

Xu P, Wu J, Yang C, Luo T, Shen X, Zhang Y, Nsofor CA, Zhu G, Gicquel B, Gao Q.

Tuberculosis (Edinb). 2016 May;98:56-61. doi: 10.1016/j.tube.2016.02.008. Epub 2016 Mar 3.

18.

In reply.

Takiff H, Alame-Emane AK, Pierre-Audigier C, Gicquel B.

Int J Tuberc Lung Dis. 2016 Feb;20(2):282-3. doi: 10.5588/ijtld.15.0628-2. No abstract available.

PMID:
26792487
19.

Bacterial infection remodels the DNA methylation landscape of human dendritic cells.

Pacis A, Tailleux L, Morin AM, Lambourne J, MacIsaac JL, Yotova V, Dumaine A, Danckaert A, Luca F, Grenier JC, Hansen KD, Gicquel B, Yu M, Pai A, He C, Tung J, Pastinen T, Kobor MS, Pique-Regi R, Gilad Y, Barreiro LB.

Genome Res. 2015 Dec;25(12):1801-11. doi: 10.1101/gr.192005.115. Epub 2015 Sep 21.

20.

Biomarkers for risk of developing active tuberculosis in contacts of TB patients: a prospective cohort study.

Rakotosamimanana N, Richard V, Raharimanga V, Gicquel B, Doherty TM, Zumla A, Rasolofo Razanamparany V.

Eur Respir J. 2015 Oct;46(4):1095-103. doi: 10.1183/13993003.00263-2015. Epub 2015 Aug 6.

21.

Ecto-5'-Nucleotidase (CD73) Deficiency in Mycobacterium tuberculosis-Infected Mice Enhances Neutrophil Recruitment.

Petit-Jentreau L, Jouvion G, Charles P, Majlessi L, Gicquel B, Tailleux L.

Infect Immun. 2015 Sep;83(9):3666-74. doi: 10.1128/IAI.00418-15. Epub 2015 Jul 6.

22.

Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance.

Alame-Emane AK, Xu P, Pierre-Audigier C, Cadet-Daniel V, Shen X, Sraouia M, Siawaya JF, Takiff H, Gao Q, Gicquel B.

Int J Tuberc Lung Dis. 2015 Jun;19(6):679-84. doi: 10.5588/ijtld.14.0768.

PMID:
25946359
23.

bacterial infection drives the expression dynamics of microRNAs and their isomiRs.

Siddle KJ, Tailleux L, Deschamps M, Loh YH, Deluen C, Gicquel B, Antoniewski C, Barreiro LB, Farinelli L, Quintana-Murci L.

PLoS Genet. 2015 Mar 20;11(3):e1005064. doi: 10.1371/journal.pgen.1005064. eCollection 2015 Mar. Erratum in: PLoS Genet. 2015 Jun;11(6):e1005321.

24.

Hyper-attenuated MTBVAC erp mutant protects against tuberculosis in mice.

Solans L, Uranga S, Aguilo N, Arnal C, Gomez AB, Monzon M, Badiola JJ, Gicquel B, Martin C.

Vaccine. 2014 Sep 8;32(40):5192-7. doi: 10.1016/j.vaccine.2014.07.047. Epub 2014 Jul 25.

PMID:
25066740
25.

Extracellular adenosine triphosphate affects the response of human macrophages infected with Mycobacterium tuberculosis.

Dubois-Colas N, Petit-Jentreau L, Barreiro LB, Durand S, Soubigou G, Lecointe C, Klibi J, Rezaï K, Lokiec F, Coppée JY, Gicquel B, Tailleux L.

J Infect Dis. 2014 Sep 1;210(5):824-33. doi: 10.1093/infdis/jiu135. Epub 2014 Mar 5.

PMID:
24604822
26.

A genomic portrait of the genetic architecture and regulatory impact of microRNA expression in response to infection.

Siddle KJ, Deschamps M, Tailleux L, Nédélec Y, Pothlichet J, Lugo-Villarino G, Libri V, Gicquel B, Neyrolles O, Laval G, Patin E, Barreiro LB, Quintana-Murci L.

Genome Res. 2014 May;24(5):850-9. doi: 10.1101/gr.161471.113. Epub 2014 Jan 30.

27.

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials.

Arbues A, Aguilo JI, Gonzalo-Asensio J, Marinova D, Uranga S, Puentes E, Fernandez C, Parra A, Cardona PJ, Vilaplana C, Ausina V, Williams A, Clark S, Malaga W, Guilhot C, Gicquel B, Martin C.

Vaccine. 2013 Oct 1;31(42):4867-73. doi: 10.1016/j.vaccine.2013.07.051. Epub 2013 Aug 17.

PMID:
23965219
28.

Expression of TNF-alpha-dependent apoptosis-related genes in the peripheral blood of Malagasy subjects with tuberculosis.

Rakotosamimanana N, Doherty TM, Andriamihantasoa LH, Richard V, Gicquel B, Soares JL, Zumla A, Razanamparany VR.

PLoS One. 2013 Apr 12;8(4):e61154. doi: 10.1371/journal.pone.0061154. Print 2013.

29.

Systems approach to tuberculosis vaccine development.

Wang CC, Zhu B, Fan X, Gicquel B, Zhang Y.

Respirology. 2013 Apr;18(3):412-20. doi: 10.1111/resp.12052.

30.

High throughput phenotypic selection of Mycobacterium tuberculosis mutants with impaired resistance to reactive oxygen species identifies genes important for intracellular growth.

Mestre O, Hurtado-Ortiz R, Dos Vultos T, Namouchi A, Cimino M, Pimentel M, Neyrolles O, Gicquel B.

PLoS One. 2013;8(1):e53486. doi: 10.1371/journal.pone.0053486. Epub 2013 Jan 8.

31.

Fine-needle aspiration for diagnosis of tuberculous lymphadenitis in children in Bangui, Central African Republic.

Fanny ML, Beyam N, Gody JC, Zandanga G, Yango F, Manirakiza A, Rigouts L, Pierre-Audigier C, Gicquel B, Bobossi G.

BMC Pediatr. 2012 Dec 13;12:191. doi: 10.1186/1471-2431-12-191.

32.

The balance of apoptotic and necrotic cell death in Mycobacterium tuberculosis infected macrophages is not dependent on bacterial virulence.

Butler RE, Brodin P, Jang J, Jang MS, Robertson BD, Gicquel B, Stewart GR.

PLoS One. 2012;7(10):e47573. doi: 10.1371/journal.pone.0047573. Epub 2012 Oct 30.

33.

A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone.

Grzegorzewicz AE, Korduláková J, Jones V, Born SE, Belardinelli JM, Vaquié A, Gundi VA, Madacki J, Slama N, Laval F, Vaubourgeix J, Crew RM, Gicquel B, Daffé M, Morbidoni HR, Brennan PJ, Quémard A, McNeil MR, Jackson M.

J Biol Chem. 2012 Nov 9;287(46):38434-41. doi: 10.1074/jbc.M112.400994. Epub 2012 Sep 21.

34.

Identification of DNA binding motifs of the Mycobacterium tuberculosis PhoP/PhoR two-component signal transduction system.

Cimino M, Thomas C, Namouchi A, Dubrac S, Gicquel B, Gopaul DN.

PLoS One. 2012;7(8):e42876. doi: 10.1371/journal.pone.0042876. Epub 2012 Aug 7.

35.

'Z(S)-MDR-TB' versus 'Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility.

Zhang Y, Chiu Chang K, Leung CC, Wai Yew W, Gicquel B, Fallows D, Kaplan G, Chaisson RE, Zhang W.

Emerg Microbes Infect. 2012 Jul;1(7):e5. doi: 10.1038/emi.2012.18. Epub 2012 Jul 25. Review.

36.

Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta.

Bierne H, Travier L, Mahlakõiv T, Tailleux L, Subtil A, Lebreton A, Paliwal A, Gicquel B, Staeheli P, Lecuit M, Cossart P.

PLoS One. 2012;7(6):e39080. doi: 10.1371/journal.pone.0039080. Epub 2012 Jun 14.

37.

An interferon-related signature in the transcriptional core response of human macrophages to Mycobacterium tuberculosis infection.

Wu K, Dong D, Fang H, Levillain F, Jin W, Mei J, Gicquel B, Du Y, Wang K, Gao Q, Neyrolles O, Zhang J.

PLoS One. 2012;7(6):e38367. doi: 10.1371/journal.pone.0038367. Epub 2012 Jun 4.

38.

After the bottleneck: Genome-wide diversification of the Mycobacterium tuberculosis complex by mutation, recombination, and natural selection.

Namouchi A, Didelot X, Schöck U, Gicquel B, Rocha EP.

Genome Res. 2012 Apr;22(4):721-34. doi: 10.1101/gr.129544.111. Epub 2012 Feb 29.

39.

Mycobacterium abscessus: a new antibiotic nightmare.

Nessar R, Cambau E, Reyrat JM, Murray A, Gicquel B.

J Antimicrob Chemother. 2012 Apr;67(4):810-8. doi: 10.1093/jac/dkr578. Epub 2012 Jan 30. Review.

PMID:
22290346
40.

Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis.

Pierre-Audigier C, Surcouf C, Cadet-Daniel V, Namouchi A, Heng S, Murray A, Guillard B, Gicquel B.

Int J Tuberc Lung Dis. 2012 Feb;16(2):221-3, i-ii. doi: 10.5588/ijtld.11.0266.

PMID:
22236923
41.

Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection.

Barreiro LB, Tailleux L, Pai AA, Gicquel B, Marioni JC, Gilad Y.

Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1204-9. doi: 10.1073/pnas.1115761109. Epub 2012 Jan 10.

42.

Combination of single nucleotide polymorphism and variable-number tandem repeats for genotyping a homogenous population of Mycobacterium tuberculosis Beijing strains in China.

Luo T, Yang C, Gagneux S, Gicquel B, Mei J, Gao Q.

J Clin Microbiol. 2012 Mar;50(3):633-9. doi: 10.1128/JCM.05539-11. Epub 2012 Jan 11.

43.

Population variation in NAIP functional copy number confers increased cell death upon Legionella pneumophila infection.

Boniotto M, Tailleux L, Lomma M, Gicquel B, Buchrieser C, Garcia S, Quintana-Murci L.

Hum Immunol. 2012 Feb;73(2):196-200. doi: 10.1016/j.humimm.2011.10.014. Epub 2011 Oct 23.

PMID:
22067212
44.

Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes.

Surcouf C, Heng S, Pierre-Audigier C, Cadet-Daniel V, Namouchi A, Murray A, Gicquel B, Guillard B.

BMC Infect Dis. 2011 Sep 28;11:255. doi: 10.1186/1471-2334-11-255.

45.

Mycobacterial p(1)-type ATPases mediate resistance to zinc poisoning in human macrophages.

Botella H, Peyron P, Levillain F, Poincloux R, Poquet Y, Brandli I, Wang C, Tailleux L, Tilleul S, Charrière GM, Waddell SJ, Foti M, Lugo-Villarino G, Gao Q, Maridonneau-Parini I, Butcher PD, Castagnoli PR, Gicquel B, de Chastellier C, Neyrolles O.

Cell Host Microbe. 2011 Sep 15;10(3):248-59. doi: 10.1016/j.chom.2011.08.006.

46.

Spoligotyping of clinical Mycobacterium tuberculosis isolates from the state of Minas Gerais, Brazil.

Miranda SS, Carvalho Wda S, Suffys PN, Kritski AL, Oliveira M, Zarate N, Zozio T, Rastogi N, Gicquel B.

Mem Inst Oswaldo Cruz. 2011 May;106(3):267-73.

47.

Genetic analysis of new 16S rRNA mutations conferring aminoglycoside resistance in Mycobacterium abscessus.

Nessar R, Reyrat JM, Murray A, Gicquel B.

J Antimicrob Chemother. 2011 Aug;66(8):1719-24. doi: 10.1093/jac/dkr209. Epub 2011 Jun 7.

48.

New tuberculosis vaccines.

Martín Montañés C, Gicquel B.

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 1:57-62. doi: 10.1016/S0213-005X(11)70019-2. Review.

PMID:
21420568
49.

A first assessment of the genetic diversity of Mycobacterium tuberculosis complex in Cambodia.

Zhang J, Heng S, Le Moullec S, Refregier G, Gicquel B, Sola C, Guillard B.

BMC Infect Dis. 2011 Feb 7;11:42. doi: 10.1186/1471-2334-11-42.

50.

Phylogeny of Mycobacterium tuberculosis Beijing strains constructed from polymorphisms in genes involved in DNA replication, recombination and repair.

Mestre O, Luo T, Dos Vultos T, Kremer K, Murray A, Namouchi A, Jackson C, Rauzier J, Bifani P, Warren R, Rasolofo V, Mei J, Gao Q, Gicquel B.

PLoS One. 2011 Jan 20;6(1):e16020. doi: 10.1371/journal.pone.0016020.

Supplemental Content

Loading ...
Support Center